Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheol-Ho Kim

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Clinical Therapeutics|December 6, 2011
Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority studySeok-Min Kang, Jong-Chan Youn, Shung Chull Chae, et al.
Journal of Korean Medical Science|March 19, 2024
Characteristics According to Frailty Status Among Older Korean Patients With HypertensionJung-Yeon Choi, Hae-Young Lee, Ju-Hee Lee, et al.
Hypertension (Dallas, Tex. : 1979)|March 21, 2024
Association Between Orthostatic Hypertension and Frailty Among Older Patients With HypertensionJung-Yeon Choi, Dong Ryeol Ryu, Hae-Young Lee, et al.
Clinical Therapeutics|October 11, 2016
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter StudyChang Gyu Park, Tae Hun Ahn, Eun Ju Cho, et al.
Drug Design, Development and Therapy|June 18, 2015
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapyMoo-Yong Rhee, Sang Hong Baek, Weon Kim, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 11, 2023
Current realities of home blood pressure monitoring from physicians' perspectives: results from Asia HBPM survey 2020Tzung-Dau Wang, Takayoshi Ohkubo, Ma Lourdes Bunyi, et al.
Journal of Hypertension|June 6, 2017
Relation between secondhand smoke exposure and cardiovascular risk factors in never smokersSehun Kim, Si-Hyuck Kang, Donghoon Han, et al.
Clinical Therapeutics|October 16, 2016
Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III StudySang-Hyun Kim, Sang-Ho Jo, Sang-Cheol Lee, et al.
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Clinical Therapeutics|December 6, 2011
Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority studySeok-Min Kang, Jong-Chan Youn, Shung Chull Chae, et al.
Journal of Korean Medical Science|March 19, 2024
Characteristics According to Frailty Status Among Older Korean Patients With HypertensionJung-Yeon Choi, Hae-Young Lee, Ju-Hee Lee, et al.
Hypertension (Dallas, Tex. : 1979)|March 21, 2024
Association Between Orthostatic Hypertension and Frailty Among Older Patients With HypertensionJung-Yeon Choi, Dong Ryeol Ryu, Hae-Young Lee, et al.
Clinical Therapeutics|October 11, 2016
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter StudyChang Gyu Park, Tae Hun Ahn, Eun Ju Cho, et al.
Drug Design, Development and Therapy|June 18, 2015
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapyMoo-Yong Rhee, Sang Hong Baek, Weon Kim, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 11, 2023
Current realities of home blood pressure monitoring from physicians' perspectives: results from Asia HBPM survey 2020Tzung-Dau Wang, Takayoshi Ohkubo, Ma Lourdes Bunyi, et al.
Journal of Hypertension|June 6, 2017
Relation between secondhand smoke exposure and cardiovascular risk factors in never smokersSehun Kim, Si-Hyuck Kang, Donghoon Han, et al.
Clinical Therapeutics|October 16, 2016
Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III StudySang-Hyun Kim, Sang-Ho Jo, Sang-Cheol Lee, et al.
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Pageof 12